Naloxone hydrochlor
Ended Awarded Last action
- Contract number
- SPE2DP25F6678
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $33,075
Award facts
- Contract value 100% obligated
- $33,075.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | -$223 | |
| Original award | $33,299 |
About this award
The Defense Logistics Agency, through its Medical Supply Chain office, awarded a delivery order valued at $33,075.24 to DMS Pharmaceutical Group Inc. on May 7, 2025, for the supply of Naloxone Hydrochloride. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a continuation of ongoing pharmaceutical supply support to military health facilities. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation, competing on an open basis within the federal procurement marketplace.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026. The larger IDC vehicle, established under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare operations worldwide. The award of naloxone hydrochloride—a critical emergency medication for opioid overdose reversal—reflects the ongoing medical supply requirements of military health facilities and underscores DMS Pharmaceutical Group's established role as a key supplier within the federal pharmaceutical distribution network.
Quick answers
Who was awarded contract SPE2DP25F6678?
SPE2DP25F6678 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on May 7, 2025.
How much is contract SPE2DP25F6678 worth?
The government has obligated $33,075 on SPE2DP25F6678.
Is contract SPE2DP25F6678 an order under another contract?
Yes. SPE2DP25F6678 is a delivery order under SPE2DX15D9383, an indefinite delivery contract.
Was contract SPE2DP25F6678 competed?
The extent of competition for SPE2DP25F6678 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award